Stocktoria
KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · IPO 2025-03-06
KESTRA MEDICAL TECHNOLOGIES, LTD. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 40.5% | 1.3% |
| Operating margin | -177.8% | -305.8% |
| Net margin | -190.3% | -338.4% |
| FCF margin | -168.1% | -303.7% |
| Return on assets | -38.5% | -204.8% |
| Return on equity | -55.4% | 45.0% |
| Debt / equity | 0.20× | -0.20× |
| Current ratio | 6.72 | 0.45 |
| Revenue growth | 115.1% | — |
Source: SEC EDGAR filings · CIK 0001877184 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.